de Moor et al. Page 561

Cancer survivors represent a growing population. de Moor and colleagues offer projections on U.S. cancer survivorship based on data from the Surveillance, Epidemiology, and End Results program and population data from the U.S. Census Bureau. The authors report cancer survivor prevalence estimates overall, by cancer site, and by time since diagnosis. These important data will inform recommendations for survivorship research and practice. Furthermore, this detailed information about the cancer survivor population is crucial for policy makers.

Kobayashi et al. Page 571

Accurate diagnostic biomarkers for pancreatic cancer are greatly needed. To address this problem, Kobayashi and colleagues compared serum metabolites from patients with pancreatic cancer and chronic pancreatitis with healthy control subjects to generate a pancreatic cancer diagnostic model. The authors report that their model possessed high sensitivity and high specificity and displayed a lower false-positive rate when compared with conventional markers. This article presents a promising method for improving the prognosis of pancreatic cancer through early detection and discrimination from chronic pancreatitis.

Roland et al. Page 580

Cervical cancer screening guidelines have evolved in the past decade, promoting later initiation of screening and longer intervals between screens. Using self-reported cross-sectional National Health Interview Survey 2000–2010 data, Roland and colleagues examined trends in Papanicolaou (Pap) testing among U.S. women ages 18 to 29 years. The percentage of young women who reported ever having a Pap test significantly decreased from 2000 to 2010, and many young women reported that it had been more than 12 months since their last Pap test.

Zeigler-Johnson et al. Page 589

Early-onset baldness has been linked to prostate cancer. Zeigler-Johnson and colleagues explored this relationship in African American men, who are at elevated prostate cancer risk. The authors evaluated the associations between prostate cancer and baldness, family history, alcohol intake, smoking, and androgen metabolism genotype. In African Americans, early-onset baldness was associated with prostate cancer. Future studies are needed to uncover the mechanisms influencing this relationship.